Skip to primary navigation
Skip to main content
Join our community
Login
Enter your search
About
Editorial Board
About the Forum
Mission Statement
From the Editors
Expert Commentaries
Videos
News
Expert Meetings
Meeting Reports
News
Trials
About Trials
ANGPTL3 Inhibitors
ApoCIII Inhibitors
Icosapent Ethyl
SPPARM
View all Trials
Slides
Videos
Library
Guidelines
Key Publications
Resources
Forthcoming Meetings
Links
Register
Olezarsen (formerly AKCEA-APOCIII-LRx)
You are here:
Home
> Archives for
ApoCIII inhibitors
> Olezarsen (formerly AKCEA-APOCIII-LRx)
Ongoing Trials
The BALANCE study
Completed Trials
Phase 2 study of AKCEA-APOCIII-LRx in patients with hypertriglyceridaemia and established cardiovascular disease (CVD) (NCT03385239)
Phase 1/2a safety, tolerability, PK and PD study of AKCEA-APOCIII-LRx in healthy volunteers with elevated triglycerides (NCT0290027)
Educational partners and supporters
